Merrill Upgrades Cymer to 'Near-Term Buy'

Analyst Brett Hodess says fourth-quarter results beat his estimates as the tool manufacturer shifted to more expensive products

Merrill Lynch upgraded Cymer (CYMI ) to near-term buy from neutral.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.